Table 2. Hazard ratios (HRs) for death and recurrence with 95% confidence intervals (CIs) according to partner's vital status among 21 213 women with breast cancer diagnosed in 1994–2006, Denmark.
Crude
a
|
Adjusted HR
b
|
Adjusted HR
c
|
|||||||
---|---|---|---|---|---|---|---|---|---|
N | Person years | Events | HR | (95% CI) | HR | (95% CI) | HR | (95% CI) | |
All-cause mortality | |||||||||
Partner alive at exit (ref.) | 18 192 | 144 410 | 4977 | 1.00 | 1.00 | 1.00 | |||
Exposed in the 4 years before diagnosis | 762 | 5216 | 243 | 1.14 | (1.00, 1.30) | 1.07 | (0.94, 1.22) | 1.10 | (0.95, 1.27) |
Exposed 0–17 years after diagnosis | 2259 | 23 147 | 440 | 1.12 | (1.01, 1.25) | 1.09 | (0.98, 1.20) | 1.09 | (0.98, 1.22) |
Recurrence | |||||||||
Partner alive at exit (ref.) | 19 312 | 86 453 | 2635 | 1.00 | 1.00 | 1.00 | |||
Exposed in the 4 years before diagnosis | 762 | 2839 | 59 | 0.83 | (0.64, 1.08) | 0.82 | (0.63, 1.06) | 0.82 | (0.61, 1.09) |
Exposed 0–17 years after diagnosis | 1139 | 7581 | 85 | 0.98 | (0.78, 1.22) | 0.97 | (0.78, 1.21) | 0.93 | (0.73, 1.18) |
Stratified by age at diagnosis in 1-year intervals.
Adjusted for the highest-attained educational level, disposable income, and stratified by age at diagnosis in 1-year intervals (defined in Table 1).
Adjusted for the highest-attained educational level, disposable income, period of diagnosis, comorbidity, tumour size, no. of tumour-positive lymph-nodes, hormone receptor status, malignancy grade and stratified by age at diagnosis in 1-year intervals (N=19 186) (defined in Table 1).